Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05524597
Other study ID # R01AG071498
Secondary ID
Status Recruiting
Phase Phase 1
First received
Last updated
Start date March 13, 2023
Est. completion date March 2026

Study information

Verified date May 2024
Source University of California, Los Angeles
Contact Naomi Eisenberger, Ph.D.
Phone 3108494330
Email neisenbe@ucla.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

UCLA researchers looking for healthy older adults (aged 65+) to participate in a study investigating how writing about experiences can affect your brain and body. Once a week for 6 weeks, participants will write about their experiences and fill out online questionnaires. Participants will also come to the UCLA campus to complete a neuroimaging session (fMRI), provide a blood spot sample, and fill out questionnaires 2 times: once prior to the 6-week writing period and once immediately after the 6-week writing period.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date March 2026
Est. primary completion date March 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Healthy adults age 65 years and older Exclusion Criteria: 1. current smokers 2. active, uncontrolled medical disorders 3. chronic infection (e.g., Hepatitis C, HIV) 4. use of certain medications (steroid use, opioid use) 5. psychiatric disorders (e.g., current major depression, bipolar disorder) 6. body mass index (BMI) greater than 35 7. left-handed 8. claustrophobic 9. metal in body Other exclusion criteria may apply.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Writing Intervention
Participants will be asked to write about different kinds of experiences.

Locations

Country Name City State
United States Center for Cognitive Neuroscience Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Psychological Distress Composite measure of depression, anxiety, stress (Beck Depression Inventory, Spielberger Trait Anxiety, and Perceived Stress Scale) Baseline, 6 weeks, 10 weeks
Primary Change in Social Support measure of perceived social support (Social Provisions Scale) Baseline, 6 weeks, 10 weeks
Primary Change in Social Participation measure of participation in social activities (Lifestyle Activities Questionnaire) Baseline, 6 weeks, 10 weeks
Primary Change in Inflammatory Gene Expression changes in proinflammatory gene expression Baseline, 6 weeks, 10 weeks
Primary Change in Dorsal Anterior Cingulate Cortex (dACC) Activity in response to stress Parameter estimates from dACC region-of-interest Baseline, 6 weeks
Primary Change in Anterior Insula Activity in response to stress Parameter estimates from bilateral anterior insula region-of-interest Baseline, 6 weeks
Primary Change in Amygdala Activity in response to threat Parameter estimates from bilateral amygdala region-of-interest Baseline, 6 weeks
Primary Change in Ventral Striatum Activity in response to prosocial behavior Parameter estimates from bilateral ventral striatum region-of-interest Baseline, 6 weeks
Primary Change in Septal Area Activity in response to prosocial behavior Parameter estimates from septal area region-of-interest Baseline, 6 weeks
Secondary Change in Memory changes in recall ability (Montreal Cognitive Assessment Test) Baseline, 6 weeks, 10 weeks
Secondary Change in Beliefs about Aging changes in cognitive, affective, and social beliefs about aging (Expectations Regarding Aging survey) Baseline, 6 weeks, 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT02472379 - Writing About Experiences and Health in Older Adults N/A
Completed NCT01680718 - Neuropeptides and Social Behavior Phase 0
Active, not recruiting NCT05208723 - Addressing Stress Amongst Female Entrepreneurs in Addis Ababa, Ethiopia: a Pilot Study N/A
Completed NCT02393443 - Oxytocin and Learning for Teaching Early Phase 1
Completed NCT02394054 - Vasopressin and the Social Brain Early Phase 1
Completed NCT02393456 - Oxytocin and the Social Brain Early Phase 1
Completed NCT04064775 - The Influence of Fictitious Peers in a Social Media Intervention for Downsizing Portions: The Smart Snacking Studies N/A